European Commission logo
Horizon Europe Cluster 3 — Civil Security & Disaster Resilience

Evidence-Based Responses to Synthetic Drugs and Stimulants

Funds evidence, harm-reduction practice and civil-security tools to address synthetic drugs, violence and trafficking across Europe.

ScheduledEuropean CommissionEU

Synthetic drugs and stimulants are changing European drug markets, but evidence for emerging substances, risk assessment, prevention, treatment and harm reduction remains incomplete. This Innovation Action supports a comprehensive civil-security response that connects researchers, policymakers, Police Authorities, Civil Society Organisations and NGOs.

Projects should evaluate effective interventi

Build evidence-based prevention, treatment and harm-reduction responses to synthetic drugs and stimulants, while reducing associated violence, offending and trafficking from origin to destination. Study pharmacological, social, gender, age, legal, economic and geopolitical drivers; develop practitioner tools and technology; and balance societal and technological research at TRL 6–8.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.4 Nov 2027
Decision timeiTypical time from the deadline to the funder's decision.22 weeks
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.30%
Funding pooliThe total budget available across all awards in this round.€8M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 25 Aug 2026Funder reference: HORIZON-CL3-2027-01-FCT-05Source: ec.europa.eu